Shailendra Giri Selected Research

Coenzyme A (CoA)

9/2006	Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
1/2004	Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shailendra Giri Research Topics

Disease

19	Neoplasms (Cancer) 10/2023 - 11/2005
18	Inflammation (Inflammations) 02/2024 - 05/2004
15	Multiple Sclerosis 12/2023 - 01/2004
14	Ovarian Neoplasms (Ovarian Cancer) 03/2022 - 05/2011
11	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2023 - 01/2004
8	Demyelinating Diseases (Demyelinating Disease) 09/2023 - 05/2002
6	Globoid Cell Leukodystrophy (Krabbe Disease) 06/2008 - 05/2002
5	Endophthalmitis (Ophthalmia) 01/2024 - 12/2016
5	Disease Progression 09/2023 - 12/2015
4	Infections 01/2024 - 06/2010
4	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 06/2009
4	Bacterial Infections (Bacterial Infection) 09/2023 - 01/2019
4	Brain Ischemia (Cerebral Ischemia) 01/2007 - 05/2004
3	Zika Virus Infection 03/2024 - 01/2018
3	Ovarian Epithelial Carcinoma 01/2017 - 08/2014
3	Glioma (Gliomas) 01/2014 - 05/2002
3	Stroke (Strokes) 05/2006 - 05/2004
2	Relapsing-Remitting Multiple Sclerosis 01/2024 - 09/2006
2	Virus Diseases (Viral Diseases) 01/2021 - 06/2010
2	Eye Infections 01/2020 - 12/2016
2	Cognitive Dysfunction 01/2018 - 02/2015
2	Ataxia (Dyssynergia) 01/2018 - 11/2014
2	Carcinoma (Carcinomatosis) 04/2016 - 01/2014
2	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2016 - 02/2014
2	Peroxisomal Disorders (Peroxisomal Disorder) 01/2016 - 02/2014
2	Obesity 07/2012 - 08/2006
2	Astrocytoma (Pilocytic Astrocytoma) 02/2012 - 11/2003
1	Heart Failure 09/2022
1	Diabetes Mellitus 09/2022

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 12/2023 - 05/2002
10	Metformin (Glucophage)FDA LinkGeneric 03/2022 - 06/2009
8	AMP-Activated Protein KinasesIBA 01/2016 - 11/2005
7	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 01/2014
7	LipidsIBA 01/2024 - 08/2006
7	AICA ribonucleotide (ZMP)IBA 01/2020 - 07/2005
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2005
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2023 - 01/2014
5	Retinaldehyde (Retinal)IBA 01/2024 - 12/2016
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2015
5	Psychosine (Galactosylsphingosine)IBA 06/2008 - 05/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 05/2002
3	EnzymesIBA 12/2023 - 05/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2023 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 08/2006
3	NF-kappa B (NF-kB)IBA 12/2016 - 11/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015 - 08/2014
3	S-NitrosoglutathioneIBA 01/2014 - 02/2005
2	Messenger RNA (mRNA)IBA 12/2023 - 04/2016
2	Glutathione (Reduced Glutathione)IBA 09/2023 - 05/2004
2	Antineoplastic Agents (Antineoplastics)IBA 03/2023 - 01/2014
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2022 - 01/2020
2	Acetyl-CoA CarboxylaseIBA 01/2020 - 12/2016
2	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 01/2014
2	Adenosine Monophosphate (AMP)IBA 12/2016 - 08/2014
2	Phosphotransferases (Kinase)IBA 12/2016 - 08/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2016 - 06/2005
2	ceric oxide (cerium dioxide)IBA 03/2016 - 01/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2016 - 11/2014
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 01/2015
2	Insulin (Novolin)FDA Link 05/2015 - 08/2014
2	LeptinIBA 05/2015 - 08/2014
2	Drinking WaterIBA 05/2015 - 05/2011
2	Sirtuin 1IBA 08/2014 - 07/2012
2	AdipokinesIBA 07/2014 - 08/2006
2	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 05/2011
2	Coenzyme A (CoA)IBA 09/2006 - 01/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2006 - 07/2005
2	Oxidoreductases (Dehydrogenase)IBA 09/2006 - 01/2004
2	Lovastatin (Mevacor)FDA LinkGeneric 07/2005 - 01/2004
2	Free RadicalsIBA 06/2005 - 05/2004
2	beta-Galactosidase (Lactaid)IBA 09/2002 - 05/2002
1	CholesterolIBA 03/2024
1	Carrier Proteins (Binding Protein)IBA 03/2024
1	VaccinesIBA 03/2024
1	Antiviral Agents (Antivirals)IBA 03/2024
1	SterolsIBA 03/2024
1	margaric acid (heptadecanoic acid)IBA 02/2024
1	alpha-ketoisocaproic acidIBA 02/2024
1	Glycerol (Glycerine)FDA LinkGeneric 02/2024
1	Valine (L-Valine)FDA Link 02/2024
1	OxylipinsIBA 01/2024
1	Interleukin-10 (Interleukin 10)IBA 09/2023
1	Neuroprotective AgentsIBA 09/2023
1	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 09/2023
1	Docosahexaenoic AcidsIBA 09/2023
1	CuprizoneIBA 08/2023
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 09/2022
1	Aldehyde DehydrogenaseIBA 09/2022
1	Eicosapentaenoic AcidIBA 03/2022
1	IsoflavonesIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	TransferasesIBA 11/2021
1	dihydrolipoamideIBA 11/2021

Therapy/Procedure

13	Therapeutics 03/2024 - 01/2004
4	Oral Administration 09/2023 - 01/2007
3	Drug Therapy (Chemotherapy) 01/2017 - 05/2015
2	Ischemic Postconditioning 10/2018 - 02/2015
2	Caloric Restriction 05/2015 - 08/2014
1	Injections 09/2023
1	Intravitreal Injections 09/2023